PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25043067-3	2014	This study sought to evaluate the efficacy and safety of HELIOS completed biodegradable polymer sirolimus-eluting stent (SES) in de novo coronary lesions.	ses	121-124	IKAROS family zinc finger 2	Homo sapiens	57-63	
25043067-12	2014	CONCLUSIONS: In the HOPE trial, the novel completed biodegradable polymer SES HELIOS was non-inferior to the durable polymer SES PARTNER with respect to nine-month in-stent LLL in de novo coronary lesions.	ses	74-77	IKAROS family zinc finger 2	Homo sapiens	78-84